SARS-CoV-2 & Flu A/B
RNA STAR Complete
Test Benefits
The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete multiplex assay is intended for the rapid qualitative detection and differentiation of nucleic acid from the SARS-CoV-2, Influenza A, and/or Influenza B viruses in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19 and/or influenza by their healthcare provider
- Reliable and robust performance when compared to traditional RT-PCR tests.
- Direct amplification within 20 minutes drives lab’s efficiency and productivity.
Test Workflows
Test Performance
Join the Fast Lab Network
For more information about LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete:
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.
BetterHealthExperiencesOutcomes
Supporting healthier lives, for individuals, communities and wider society.
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.